Register to receive a free U.S. Market Report Suite for Small Bone and Joint Orthopedic Devices report synopsis and brochure
Arthrosurface Launches OsteoMATE for the Treatment of Osteoarthritis in the Hand
Arthrosurface, Inc. recently announced the first surgery using the new OsteoMATE™ arthrodesis implant. The procedure was performed by David Ruch, MD Professor of Orthopaedic Surgery, Duke Orthopaedic Surgery, Durham, NC.
The OsteoMATE™ arthrodesis implant is comprised of allograft bone; provided pre-shaped, pre-drilled and sterile. The OsteoMATE™ implant design is optimized for Four Corner Fusion of the hand and Lisfranc arthrodesis of the foot. The selection of allograft bone as the implant material was chosen to mitigate non-union of the fusion area, which in the literature has been reported to be as high as 31% with traditional metal implants.
Benefits of the OsteoMATE implant are:
- The diseased bone, which is removed to make room for the implant, is replaced with allograft bone, not metal or polymer. The implant provides a 360 degree contact to the patient’s native bone to facilitate bony incorporation.
- Allograft bone is translucent under x-ray allowing the physician to visualize and monitor bone ingrowth during the healing period, which cannot be seen under a metal implant.
The first surgery involved a Four Corner Fusion procedure for a patient who suffered from pain related osteoarthritis of the hand. “I was very happy with the ease of use of this implant,” said David Ruch, MD. “The procedural steps were concise and straightforward, the instrumentation kit allowed my staff to quickly prepare for this surgery with minimal time and effort.”
“Arthrosurface is pleased to add these new orthobiological solutions to our existing extremities portfolio,” said Joe Darling, Executive Chairman of Arthrosurface. “We now are able to address a wider disease spectrum and offer more complete solutions for physicians caring for patients suffering from osteoarthritis of both the hand & wrist and the foot.”
Conventus Orthopaedics Raises $20 Million to Fund Revolutionary Cage™ Extremity Fracture Repair Therapy
Conventus Orthopaedics, Inc., a medical device company dedicated to revolutionizing extremity fracture treatment, today announced the completion of a $20 million equity financing. Deerfield Management led the financing which was funded entirely by the existing ownership syndicate.
The Conventus CageTM is an intramedullary implant for the repair of extremity fractures, currently FDA cleared for the treatment of shoulder, elbow and wrist fractures. Early clinical results have been promising as patients have experienced a stable fracture fixation with a quicker recovery period, less pain, improved range of motion, and fewer surgical complications when compared to historical literature for existing fracture repair methods.
Scott Flora, Conventus’ Executive Chairman, said, “The CageTM is the future of fracture repair. We are pleased that our investor syndicate, led by Deerfield, share that vision and continue to provide financial support with a long-term view to realize the full potential of this technology.”
“The CageTM is a truly innovative technology, poised to disrupt the orthopaedic trauma market.” said Avi Kometz, MD, Partner at Deerfield Management. “The early clinical results have been outstanding, leading us to continue our long-term investment thesis in the company.”
For Further Information
More on the small bone and joint market in the U.S. can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Small Bone and Joint Orthopedic Devices. The suite covers reports on the following markets: Shoulder Reconstruction Devices, Elbow Reconstruction Devices, Hand and Wrist Devices and Foot and Ankle Devices.
The iData report series on small bone and joint devices covers the United States, Japan, India, China, Brazil and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about small bone and joint device market data or procedure data, register online or email us at [email protected] for a U.S. Market Report Suite for Small Bone and Joint Orthopedic Devices brochure and synopsis.
About iData Research
iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Anesthesiology, Wound Management, Orthopedics and more.
We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.